Andria Rae Crisler

Apr 8, 2024 | jdsupra.com | Philip Chen |Andria Rae Crisler |Casey Kraning Ph.D

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant disputes on biologic drug patents before the United States Patent and Trademark Office (USPTO), and proposed legislation and regulatory activities relating to biosimilars.

Apr 5, 2024 | fr.com | Andria Rae Crisler |Casey Kraning |Philip Chen |Madelyn McCormick

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA), post-grant disputes on biologic drug patents before the United States Patent and Trademark Office (USPTO), and proposed legislation and regulatory activities relating to biosimilars.

Feb 7, 2024 | jdsupra.com | Andria Rae Crisler

This post reviews developments from the Northern, Southern, Eastern, and Western Districts of Texas in December 2023. Northern DistrictStarting with the Northern District, on December 7, 2023, Chief Judge David Godbey issued Special Order No. 3-351 referring all cases assigned to former Magistrate Judge Irma C. Ramirez to other magistrate judges in the Dallas Division. On December 4, 2023, Judge Ramirez was confirmed as a circuit judge for the Fifth Circuit Court of Appeals.